Kayhan Erturk

Kayhan Erturk

Prof. Dr. Cemil Tascioglu City Hospital
Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group.

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group.

Journal: BMC cancer

Published: June 04, 2026

Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years.

Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years.

Journal: BMC cancer

Published: April 09, 2026

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study.

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study.

Journal: Scientific reports

Published: March 19, 2026

Prognostic value of PSMA PET-derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Prognostic value of PSMA PET-derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: February 10, 2026

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study.

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study.

Journal: Breast cancer research : BCR

Published: January 17, 2026

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Journal: BMC cancer

Published: November 30, 2025

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study.

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study.

Journal: Cancer management and research

Published: November 21, 2025

Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma.

Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma.

Journal: Biomarkers in medicine

Published: November 17, 2025

Associations of Increasing Serum Lactate Dehydrogenase Levels With Chemotherapy Responsiveness and Survival in Patients With Extensive Disease Small Cell Lung Cancer.

Associations of Increasing Serum Lactate Dehydrogenase Levels With Chemotherapy Responsiveness and Survival in Patients With Extensive Disease Small Cell Lung Cancer.

Journal: American journal of therapeutics

Published: September 18, 2025

Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

Journal: Medicine

Published: September 17, 2025

Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study.

Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study.

Journal: Scientific reports

Published: September 06, 2025

Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience.

Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience.

Journal: Medicine

Published: August 05, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026